P940-4351 Screening compound: 3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one

P940-4351 Screening compound: 3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one
P940-4351 Screening compound: 3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P940-4351
3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P940-4351

Molecular Formula

C17H26N6O2 (C17 H26 N6 O2)

Compound Name

3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one

IUPAC name

3-[1-(1-ethyl-1H-pyrazole-3-carbonyl)piperidin-3-yl]-1-methyl-4-(propan-2-yl)-45-dihydro-1H-124-triazol-5-one

SMILES

CCn(cc1)nc1C(N(CCC1)CC1C(N1C(C)C)=NN(C)C1=O)=O

InChI

InChI=1S/C17H26N6O2/c1-5-22-10-8-14(18-22)16(24)21-9-6-7-13(11-21)15-19-20(4)17(25)23(15)12(2)3/h8,10,12-13H,5-7,9,11H2,1-4H3/t13-/m0/s1

InChI Key

KLOGWDQZZTZTPA-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD32224157

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

346.43

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.341

Distribution Coefficient, logD

1.339

Water Solubility, LogSw

-1.56

Polar Surface Area

63.055

Acid Dissociation Constant (pKa)

22.60

Base Dissociation Constant (pKb)

-3.23

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

64.71

P940-4351 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with P940-4351 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P940-4351?
Check Price and Availability of P940-4351, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P940-4351 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P940-4351
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P940-4351
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P940-4351 available by request